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The present thesis focuses on the fabrication of bio-stimuli responsive micro- and 
nano-carriers for drug delivery applications.  In particular, the objective of this 
work is to investigate the possibility of using polypeptide drug protamine and  
glycosaminoglycan drug, chondroitin sulphate as stimuli responsive components 
in the design of bioresponsive carriers. These biopolymers are biocompatible, 
biodegradable and clinically used for various applications.  
 Two designs that incorporate these stimuli responsive components have 
been studied in this thesis. The first design involves hollow micro and 
nanocapsules that have been fabricated by incorporating the stimuli responsive 
biopolymers as wall components. Upon exposure to biological triggers, these 
hollow capsules disintegrate releasing the encapsulated drug. The second design 
consists of mesoporous silica nanoparticles-biopolymer hybrids. The mesoporous 
silica nanoparticles act as a gated scaffold that carries the drug molecules. The 
mesopores of these drug loaded nanoparticles are then blocked with the 
bioresponsive polymers. Upon exposure to the bio-triggers which consist of 
enzymes over-expressed in conditions such as cancer and inflammation, these 
“molecular gates” disintegrate allowing the drug trapped in the mesoporous silica 
nanoparticles to escape into the surroundings.   
The thesis has been divided into five chapters: 
Chapter 1 is an introduction to bio-responsive drug delivery.  The broad 
 
 
classification of stimuli used in responsive drug delivery systems are visited. A 
brief discussion on the various types of bio-stimuli that can be utilized in 
designing bio-responsive systems is also included in this chapter. 
Chapter 2 defines the aims and scope of the thesis which is followed by an 
overview of the various design parameters involved in the fabrication of systems 
presented in this work. The major stimuli responsive components and the 
architectures incorporating these elements are discussed in detail  here. A 
literature review of the various carrier designs involved in the study is provided , 
with special emphasis on stimuli responsive drug delivery.  
Chapter 3 gives an overview of the various materials and methods involved in 
this work. A summary of the various characterisation techniques used in the 
thesis is also included along with the details of the experiments that has been 
carried out.  
Chapter 4 provides an overview of the results and discussions of the thesis. The 
chapter has been divided into six sections:  
Chapter 4.1 deals with the fabrication of a hollow microcapsule system 
incorporated with protamine as the stimuli responsive element for bio-responsive 
drug delivery. The hollow microcapsules that were fabricated by Layer by Layer 
assembly of protamine and heparin display pH responsive variations in 
permeability and disintegrate in the presence of the enzyme trypsin that degrades 
protamine. The biologically triggered enzyme responsive drug release from these 
microcapsules is also demonstrated using enzymes secreted by colorectal cancer 
cells.  
 
 
Chapter 4.2 presents nanocapsules fabricated from protamine and heparin. The 
pH and enzyme responsive drug release of this systems is evaluated in vitro. A 
wall crosslinking strategy has been tested to control the rate of drug release under 
physiological pH conditions in the absence of the trigger. The cellular 
interactions of these nanocapsules loaded with an anticancer drug, doxorubicin 
was studied using cancer cell lines. Bioavailability studies of doxorubicin 
encapsulated in these nanocapsules were performed using a BALB/c mice model.  
Chapter 4.3 discusses the fabrication of a hollow microcapsule system that can 
disintegrate in response to dual biological stimuli. These carriers have been 
fabricated by incorporating protamine and chondroitin sulphate as the wall 
components. Due to the incorporation of two separate stimuli responsive 
components in the walls, these capsules are expected to be sensitive to the 
enzymes trypsin or hyaluronidase I. 
Chapter 4.4 deals with the fabrication of dual enzyme responsive hollow 
nanocapsule which can be targeted to deliver anticancer agents specifically inside 
cancer cells. The enzyme responsive elements integrated in the hollow 
nanocapsule walls can undergo degradation in presence of either of the enzymes 
trypsin or hyaluronidase I leading to the release of encapsulated drug molecules. 
The drug release from these nanocapsules which were crosslinked and 
functionalised with folic acid, is evaluated under varying conditions. The cellular 
uptake and intracellular drug delivery by these nanocapsules were evaluated in 
cervical cancer cell lines. 
Chapter 4.5 introduces a mesoporous silica nanoparticle − protamine hybrid 
system. The system consists of a mesoporous silica nanoparticle support whose 
 
 
mesopores are capped with protamine which effectively blocks the outward 
diffusion of the drug molecules from the mesopores of the mesoporous silica 
nanoparticles. Upon exposure to the enzyme trigger, the protamine cap 
disintegrates opening up the molecular gates and releasing the entrapped drug 
molecules. The drug release from this system is evaluated in different release 
conditions in the presence and absence of the enzyme trigger. The ability of these 
particles to deliver hydrophobic anticancer drugs and induce cell death in 
colorectal cancer cells has also been demonstrated.  
Chapter 4.6 discusses the fabrication of another mesoporous silica nanoparticles 
based bio-responsive drug delivery system consisting of mesoporous silica and 
chondroitin sulphate hybrid nanoparticles. The ability of the system to modulate 
drug release in response to hyaluronidase I is demonstrated. By utilizing a 
cervical cancer cell line, we have demonstrated the cellular uptake and 
intracellular delivery of hydrophobic drugs encapsulated in these particles. 
Interestingly, the system showed ability to enhance the anticancer activity of 
hydrophobic drug curcumin in these cancer cells.  
Chapter 5 gives a summary of the  general conclusions drawn from the thesis 
work. 
